Skip to main content Accessibility help
×
Home
Hostname: page-component-568f69f84b-d8fc5 Total loading time: 0.271 Render date: 2021-09-16T12:15:10.939Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Challenges in the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy in the young

Published online by Cambridge University Press:  06 July 2021

Hirokuni Yamazawa*
Affiliation:
Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
Atsuhito Takeda
Affiliation:
Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
Gaku Izumi
Affiliation:
Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan
*Corresponding
Author for correspondence: Hirokuni Yamazawa, MD, PhD, Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, North 15 West 7, Kitaku Sapporo, Hokkaido 060-8638 Japan. Tel: 81 11 706 5954; Fax: 81 11 706 7898. E-mail: yamazawa@med.hokudai.ac.jp

Abstract

A case of hypertrophic cardiomyopathy in the transition from childhood to adulthood, which was low risk by the conventional risk assessment model, medium risk by the adult risk prediction model, and high risk by the paediatric risk prediction model, was inserted an implantable cardioverter-defibrillator. Three years post-implantation, the patient was resuscitated with an appropriate discharge of cardioverter-defibrillator.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gersh, BJ, Maron, BJ, Bonow, RO, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e212e260.CrossRefGoogle Scholar
O’Mahony, C, Jichi, F, Pavlou, M, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014; 35: 20102020.CrossRefGoogle Scholar
Yamazawa, H, Takeda, A, Takei, K, Furukawa, T. Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging. Clin Res Cardiol 2014; 103: 7577.CrossRefGoogle Scholar
Sridharan, A, Maron, BJ, Madias, C, et al. Abstract 12090: modern treatments can abolish mortality in pediatric patients with hypertrophic cardiomyopathy. Circulation 2019; 140: A12090.Google Scholar
Nakagawa, S, Okada, A, Nishimura, K, et al. Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model Among Various Phenotypes in Japanese Patients With Hypertrophic Cardiomyopathy. Am J Cardiol 2018; 122: 19391946.CrossRefGoogle Scholar
Norrish, G, Ding, T, Field, E, et al. Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids). JAMA Cardiol 2019; 4(9): 918927.CrossRefGoogle Scholar
Miron, A, Lafreniere-Roula, M, Steve Fan, CP, et al. A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy. Circulation 2020; 142: 217229.CrossRefGoogle ScholarPubMed

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Challenges in the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy in the young
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Challenges in the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy in the young
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Challenges in the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy in the young
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *